Derivatives: Anticipated adjustment due to rights issue in Active Biotech (10/08)

| Source: Derivatives Derivatives 

The following information is based on a press release from Active Biotech AB (Active Biotech) published on April 7, 2008 and may be subject to change.

The board of Active Biotech has proposed that the Annual General Meeting (AGM) approves a rights issue (1:12), whereby shareholders are entitled to one (1) new share for every twelve (12) shares held. The subscription price is set at SEK 40. The AGM will be held on May 7, 2008. The scheduled record date is May 20, 2008. Provided that the AGM approves the proposal, OMX Derivatives Markets will carry out a re-calculation of options and futures in Active Biotech.

For further details please see the attached file.

Attachments

wkr0003.pdf